Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2014

Fisher KE, Cohen C, Siddiqui MT, Palma JF, Lipford EH, Longshore JW. Accurate detection of BRAF p.V600E mutations in challenging melanoma specimens requires stringent immunohistochemistry scoring criteria or sensitive molecular assays. Hum Pathol. 2014;45(11):2281-93.

Park K, Chen Z, MacDonald TY, Siddiqui J, Ye H, Erbersdobler A, et al. Prostate cancer with Paneth cell-like neuroendocrine differentiation has recognizable histomorphology and harbors AURKA gene amplification. Hum Pathol. 2014;45(10):2136-43.

Perkins J, Scarbrough C, Sammons D, Magro C. Reed syndrome: an atypical presentation of a rare disease. Dermatol Online J. 2014;21(3).

Kiuru M, Schwartz M, Magro C. Cutaneous thrombogenic vasculopathy associated with bevacizumab therapy. Dermatol Online J. 2014;20(6).

Xia H, Bodempudi V, Benyumov A, Hergert P, Tank D, Herrera J, et al. Identification of a cell-of-origin for fibroblasts comprising the fibrotic reticulum in idiopathic pulmonary fibrosis. Am J Pathol. 2014;184(5):1369-83.

Lonze BE, Zachary AA, Magro CM, Desai NM, Orandi BJ, Dagher NN, et al. Eculizumab prevents recurrent antiphospholipid antibody syndrome and enables successful renal transplantation. Am J Transplant. 2014;14(2):459-65.

Kim D-, Rhee I, Paik J. Metabolic circuits in neural stem cells. Cell Mol Life Sci. 2014;71(21):4221-41.

Galletti G, Matov A, Beltran H, Fontugne J, Mosquera JM, Cheung C, et al. ERG induces taxane resistance in castration-resistant prostate cancer. Nat Commun. 2014;5:5548.

Greenblatt MB, Torre M, Means J, Tanasijevic M, Pedulla LV, Bunnell CA, et al. Use of potassium concentrations as a quality-of-service metric for phlebotomists detects systematic preanalytical biases and facilitates their correction. Clin Chem. 2014;60(11):1453-5.

Vitolo U, Chiappella A, Franceschetti S, Carella AM, Baldi I, Inghirami G, et al. Lenalidomide plus R-CHOP21 in elderly patients with untreated diffuse large B-cell lymphoma: results of the REAL07 open-label, multicentre, phase 2 trial. Lancet Oncol. 2014;15(7):730-7.